Our pipeline
| Program | Compound | Lead Indications | Drug Discovery | Preclinical Study | Phase I Trial | POC |
|---|---|---|---|---|---|---|
| CLK inhibitor | CTX-712 | AML, MDS, Solid cancers | ||||
| MALT1 inhibitor | CTX-177 | Non-Hodgkin Lymphoma | ||||
| CDK12 inhibitor | - | Solid cancers | ||||
| GCN2 inhibitor | - | AML, MDS, Solid cancers | ||||
| Undisclosed | - | Undisclosed |